COVID-19: Current Trends in Invitro Diagnostics

Indian journal of clinical biochemistry

article

R. Arun Krishnan¹  Rhema Elizabeth Thomas¹  Ajaikumar Sukumaran¹  Jofy K. Paul¹  D. M. Vasudevan¹ 

[1] R&D Reagent Department, Agappe Diagnostics Limited

关键词: SARS-CoV-2 Reverse transcriptase PCR Loop mediated isothermal amplification Lateral flow immunoassay ELISA CLIA Intr;   

DOI  :  10.1007/s12291-020-00906-5

来源: Springer

【 摘 要 】

The novel coronavirus SARS-CoV-2 is the seventh known species of coronavirus, infectious to human beings. The pandemic COVID-19 spread all over the world with an unprecedented spreading rate after its first appearance in Wuhan, China. As a novel viral disease there in no antiviral treatment or vaccine for the COVID-19. At present, the early detection and the quarantine of infected patients are the ways to stop the spreading of the disease. This review will discuss about the current invitro diagnostic methods used worldwide for the early and accurate diagnosis of COVID-19. Currently the nucleic acid based polymerase chain reaction is used as the reliable diagnostic platform and antigen/antibody detection immunoassays are playing the role of screening tests for early detection and prognosis in COVID-19 treatment.

【 授权许可】

Unknown